Beyond Diabetes: How SGLT2 Inhibitors Became the Surprise Heart and Kidney Drug
The sodium-glucose co-transporter 2 inhibitors, including empagliflozin, dapagliflozin, and canagliflozin, were originally developed as modest glucose-lowering medications for type 2 diabetes. Their mechanism is elegant[…]
Administrative Mailing Address:
9200 NW 39th Ave, Ste 130-3317
Gainesville, FL 32606